세계의 안티툼(Anthim) 시장 보고서(2025년) : 역학, 파이프라인 분석, 시장 인사이트 및 예측

Anthim Global Market Report 2025: Epidemiology, Pipeline Analysis, Market Insights & Forecasts

US $ 4,490 ￦ 6,290,000

PDF (Single User License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 6,490 ￦ 9,091,000

PDF (Site License)

PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 8,490 ￦ 11,893,000

PDF (Enterprise License)

PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

한글목차

안티툼 시장 규모는 향후 몇 년 동안 강력한 성장을 보일 것으로 예상됩니다. 예측 기간의 성장은 단일 클론 항체 생산의 향상, 신흥 시장의 의료 인프라 확장, 생물학적 위협 완화 전략에 대한 전 세계의 인식 제고에 기인할 수 있습니다. 예측 기간의 주요 동향으로는 첨단 바이오 의약품 연구, 생물 방어 이니셔티브에 대한 민관 협력 확대, 의약품 생산의 지역적 다양화, 의약품 승인 절차를 가속화하기 위한 규제 경로의 간소화 등이 있습니다.

박테리아 감염의 유병률이 증가함에 따라 안티툼 시장의 성장이 촉진될 것으로 예상됩니다. 유해한 박테리아가 인체에 침입하여 증식하고 독소를 생성할 때 발생하는 박테리아 감염은 항생제의 남용, 전 세계 여행, 도시화, 위생 상태의 악화, 의료 관련 감염 등의 요인으로 인해 증가하고 있습니다. 안티툼은 바실러스 안트라시스(Bacillus anthracis)에 의해 발생하는 박테리아 감염인 흡입성 탄저병을 치료하는 데 사용되는 단일 클론 항체입니다. 이 항체는 탄저 독소를 중화시켜 세포 내로 침투하는 것을 방지함으로써 그 유해한 효과를 완화합니다. 예를 들어, 세계보건기구(WHO)의 2023년 12월 보고서에 따르면 잠비아에서 2022년 9월부터 2023년 1월까지 42건이었던 탄저 의심 사례가 2023년 11월까지 684건으로 급증했으며, 이 중 4명이 사망했습니다. 박테리아 감염, 특히 탄저병의 유행이 증가하는 것은 안티툼 시장의 성장을 촉진하는 주요 요인입니다.

안티툼 시장의 주요 동향은 기술 통합을 강화하고 시장 도달 범위를 확대하기 위해 공공-민간 파트너십(PPP)과 같은 전략적 국제 계약을 채택하는 것입니다. PPP는 정부 기관과 민간 제약 회사가 협력하여 의료 치료를 공동으로 자금 지원, 연구 및 배포하며, 종종 공중 보건 요구를 해결합니다. 예를 들어, 2022년 4월, 미국에 본사를 둔 생명공학 기업인 Heat Biologics는 자회사인 Elusys Therapeutics를 통해 캐나다 정부와 565만 달러 규모의 계약을 체결했습니다. 이 계약은 캐나다 국가 비상 전략 비축 물자에 Anthim을 공급하는 것으로, 탄저균 생물학적 위협에 대응하기 위한 최초의 국제 의약품 조달 계약입니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 바이오의약품 시장에서의 제품 특성

• 분자 유형
• 투여경로(ROA)
• 작용기전(MOA)
• 안전성과 유효성

제4장 시장 동향과 전략

제5장 시장 - 거시경제 시나리오 금리, 인플레이션, 지정학, 신형 코로나 바이러스 감염, 경기 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제6장 세계의 성장 분석과 전략 분석 프레임워크

• 세계의 안티툼 : PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인과 억제요인)
• 최종 이용 산업의 분석
• 세계의 안티툼 시장 : 성장률 분석
• 세계의 안티툼 시장 실적 : 규모와 성장(2019-2024년)
• 세계의 안티툼 시장 예측 : 규모와 성장(2024-2029년, 2034년)
• 세계의 안티툼 : 전체 시장 규모(TAM)

제7장 세계 시장의 가격 분석과 예측

제8장 시장 세분화

• 세계의 안티툼 시장 : 유형별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
• 성인용
• 유아용
• 세계의 안티툼 시장 : 임상적응증별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
• 흡입 탄저병의 치료
• 흡입 탄저병의 노출 후 예방(PEP)
• 소아 및 성인의 사용
• 세계의 안티툼 시장 : 용도별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
• 병원
• 약국
• 기타

제9장 임상적응증 세계 시장 역학

• 약제의 부작용
• 임상적응증의 발병률과 유병률

제10장 지역별, 국가별 분석

• 세계의 안티툼 시장 : 지역별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
• 세계의 안티툼 시장 : 국가별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)

제11장 아시아태평양 시장

제12장 중국 시장

제13장 인도 시장

제14장 일본 시장

제15장 호주 시장

제16장 한국 시장

제17장 서유럽 시장

제18장 영국 시장

제19장 독일 시장

제20장 프랑스 시장

제21장 동유럽 시장

제22장 북미 시장

제23장 미국 시장

제24장 캐나다 시장

제25장 남미 시장

제26장 중동 시장

제27장 아프리카 시장

제28장 경쟁 구도와 기업 프로파일

• 안티툼 시장 : 경쟁 구도
• 안티툼 시장 : 기업 프로파일
  • Elusys Therapeutics Inc
  • Hikma Pharmaceuticals

제29장 세계 시장 : 파이프라인 분석

제30장 세계 시장 경쟁 벤치마킹과 대시보드

제31장 주요 인수합병(M&A)

제32장 최근 시장 동향

제33장 시장의 잠재력이 높은 국가, 전략

• 안티툼시장(2029년) : 새로운 기회를 제공하는 국가
• 안티툼 시장(2029년) : 새로운 기회를 제공하는 부문
• 안티툼 시장(2029년) : 성장 전략
  • 시장 동향에 의한 전략
  • 경쟁 전략

제34장 부록

HBR

영문 목차

영문목차

Anthim is a monoclonal antibody used to treat inhalational anthrax caused by Bacillus anthracis infection. It works by binding to the anthrax toxin, preventing it from entering cells and causing damage.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The primary types of anthim include adult and pediatric formulations. Anthim (obiltoxaximab) is indicated for use in adults as part of the treatment regimen for inhalational anthrax caused by Bacillus anthracis. Its clinical indications include treating inhalational anthrax, providing post-exposure prophylaxis (PEP) for inhalational anthrax, and its use in both pediatric and adult populations. The various distribution channels include hospitals, drug stores, and other applications.

The anthim market research report is one of a series of new reports from The Business Research Company that provides anthim market statistics, including anthim industry global market size, regional shares, competitors with a anthim market share, detailed anthim market segments, market trends, and opportunities, and any further data you may need to thrive in the anthim industry. This anthim market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The anthim market size is expected to see strong growth in the next few years. It will grow to $5,715.3 million in 2029 at a compound annual growth rate (CAGR) of 7%. The growth in the forecast period can be attributed to enhancing monoclonal antibody production, expanding healthcare infrastructure in emerging markets, and increasing global awareness of biological threat mitigation strategies. Major trends in the forecast period include advanced biopharmaceutical research, expanding public-private partnerships in biodefense initiatives, rising regional diversification in pharmaceutical production, and an emphasis on streamlined regulatory pathways to accelerate drug approval processes.

The rising prevalence of bacterial infections is expected to drive the growth of the anthim market. Bacterial infections, which occur when harmful bacteria invade the body, multiply, and produce toxins, are on the rise due to factors such as antibiotic overuse, global travel, urbanization, poor hygiene, and healthcare-associated infections. Anthim is a monoclonal antibody used to treat inhalation anthrax, a bacterial infection caused by Bacillus anthracis. It works by neutralizing the anthrax toxin and preventing it from entering cells, thus mitigating its harmful effects. For example, a report from the World Health Organization (WHO) in December 2023 revealed a significant increase in suspected anthrax cases in Zambia, from 42 cases between September 2022 and January 2023 to 684 cases by November 2023, including four deaths. This rising prevalence of bacterial infections, particularly anthrax, is a key factor fueling the growth of the anthim market.

A key trend in the anthim market is the adoption of strategic international contracts, such as public-private partnerships (PPPs), to enhance technology integration and expand market reach. PPPs involve collaborations between government agencies and private pharmaceutical companies to jointly fund, research, and distribute medical treatments, often addressing public health needs. For instance, in April 2022, Heat Biologics, a US-based biotechnology company, secured a $5.65 million contract with the Canadian government through its subsidiary Elusys Therapeutics. This contract involved supplying Anthim for the Canadian National Emergency Strategic Stockpile, marking the drug's first international procurement aimed at combating anthrax biothreats.

In April 2022, Heat Biologics, a US-based biotechnology company that offers pharmaceuticals, acquired Elusys Therapeutics expanding its biodefense portfolio. The acquisition allowed Heat Biologics to integrate Anthim into its RapidVax platform, enhance its manufacturing capabilities at a new facility in Kansas, and explore expanded global distribution opportunities. These developments highlight the growing strategic importance of Anthim in addressing anthrax threats and its potential for wider global distribution through partnerships and acquisitions.

Major players operating in the anthim market are Elusys Therapeutics Inc, and Hikma Pharmaceutical.

North America was the largest region in the anthim market in 2024. Asia Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in anthim report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the anthim market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The anthim market consists of sales of monoclonal antibodies, injectable solutions and emergency response treatments. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Anthim Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on anthim market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 10 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 3-4 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for anthim ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The anthim market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Type: Adult; Children
• 2) By Clinical Indications: Inhalational Anthrax Treatment; Post-Exposure Prophylaxis (PEP) For Inhalational Anthrax; Use In Pediatric And Adult Populations
• 3) By Application: Hospital; Drugs Store; Other Applications
• Companies Mentioned: Elusys Therapeutics Inc; Hikma Pharmaceuticals
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Anthim Market Characteristics

3. Anthim Market Biologic Drug Characteristics

• 3.1. Molecule Type
• 3.2. Route Of Administration (ROA)
• 3.3. Mechanism Of Action (MOA)
• 3.4. Safety And Efficacy

4. Anthim Market Trends And Strategies

5. Anthim Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

6. Global Anthim Growth Analysis And Strategic Analysis Framework

• 6.1. Global Anthim PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 6.2. Analysis Of End Use Industries
• 6.3. Global Anthim Market Growth Rate Analysis
• 6.4. Global Anthim Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 6.5. Global Anthim Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 6.6. Global Anthim Total Addressable Market (TAM)

7. Global Anthim Market Pricing Analysis & Forecasts

8. Anthim Market Segmentation

• 8.1. Global Anthim Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Adult
• Children
• 8.2. Global Anthim Market, Segmentation By Clinical Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Inhalational Anthrax Treatment
• Post-Exposure Prophylaxis (PEP) For Inhalational Anthrax
• Use In Pediatric And Adult Populations
• 8.3. Global Anthim Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospital
• Drugs Store
• Other Applications

9. Global Anthim Market Epidemiology Of Clinical Indications

• 9.1. Drug Side Effects
• 9.2. Incidence And Prevalence of Clinical Indications

10. Anthim Market Regional And Country Analysis

• 10.1. Global Anthim Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. Global Anthim Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Asia-Pacific Anthim Market

• 11.1. Asia-Pacific Anthim Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 11.2. Asia-Pacific Anthim Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Asia-Pacific Anthim Market, Segmentation By Clinical Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Asia-Pacific Anthim Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. China Anthim Market

• 12.1. China Anthim Market Overview
• 12.2. China Anthim Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 12.3. China Anthim Market, Segmentation By Clinical Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 12.4. China Anthim Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

13. India Anthim Market

• 13.1. India Anthim Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. India Anthim Market, Segmentation By Clinical Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. India Anthim Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. Japan Anthim Market

• 14.1. Japan Anthim Market Overview
• 14.2. Japan Anthim Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. Japan Anthim Market, Segmentation By Clinical Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. Japan Anthim Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Australia Anthim Market

• 15.1. Australia Anthim Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.2. Australia Anthim Market, Segmentation By Clinical Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Australia Anthim Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. South Korea Anthim Market

• 16.1. South Korea Anthim Market Overview
• 16.2. South Korea Anthim Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. South Korea Anthim Market, Segmentation By Clinical Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.4. South Korea Anthim Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Western Europe Anthim Market

• 17.1. Western Europe Anthim Market Overview
• 17.2. Western Europe Anthim Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Western Europe Anthim Market, Segmentation By Clinical Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.4. Western Europe Anthim Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. UK Anthim Market

• 18.1. UK Anthim Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. UK Anthim Market, Segmentation By Clinical Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. UK Anthim Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Germany Anthim Market

• 19.1. Germany Anthim Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Germany Anthim Market, Segmentation By Clinical Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Germany Anthim Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. France Anthim Market

• 20.1. France Anthim Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. France Anthim Market, Segmentation By Clinical Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. France Anthim Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Anthim Market

• 21.1. Eastern Europe Anthim Market Overview
• 21.2. Eastern Europe Anthim Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Anthim Market, Segmentation By Clinical Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Anthim Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. North America Anthim Market

• 22.1. North America Anthim Market Overview
• 22.2. North America Anthim Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. North America Anthim Market, Segmentation By Clinical Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.4. North America Anthim Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. USA Anthim Market

• 23.1. USA Anthim Market Overview
• 23.2. USA Anthim Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. USA Anthim Market, Segmentation By Clinical Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. USA Anthim Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. Canada Anthim Market

• 24.1. Canada Anthim Market Overview
• 24.2. Canada Anthim Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. Canada Anthim Market, Segmentation By Clinical Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. Canada Anthim Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. South America Anthim Market

• 25.1. South America Anthim Market Overview
• 25.2. South America Anthim Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. South America Anthim Market, Segmentation By Clinical Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. South America Anthim Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. Middle East Anthim Market

• 26.1. Middle East Anthim Market Overview
• 26.2. Middle East Anthim Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. Middle East Anthim Market, Segmentation By Clinical Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. Middle East Anthim Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Africa Anthim Market

• 27.1. Africa Anthim Market Overview
• 27.2. Africa Anthim Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Africa Anthim Market, Segmentation By Clinical Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.4. Africa Anthim Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Anthim Market Competitive Landscape And Company Profiles

• 28.1. Anthim Market Competitive Landscape
• 28.2. Anthim Market Company Profiles
  • 28.2.1. Elusys Therapeutics Inc Overview, Products and Services, Strategy and Financial Analysis
  • 28.2.2. Hikma Pharmaceuticals Overview, Products and Services, Strategy and Financial Analysis

29. Global Anthim Market Pipeline Analysis

• 29.1. High Level Clinic Trail Information

30. Global Anthim Market Competitive Benchmarking And Dashboard

31. Key Mergers And Acquisitions In The Anthim Market

32. Recent Developments In The Anthim Market

33. Anthim Market High Potential Countries, Segments and Strategies

• 33.1 Anthim Market In 2029 - Countries Offering Most New Opportunities
• 33.2 Anthim Market In 2029 - Segments Offering Most New Opportunities
• 33.3 Anthim Market In 2029 - Growth Strategies
  • 33.3.1 Market Trend Based Strategies
  • 33.3.2 Competitor Strategies

34. Appendix

• 34.1. Abbreviations
• 34.2. Currencies
• 34.3. Historic And Forecast Inflation Rates
• 34.4. Research Inquiries
• 34.5. The Business Research Company
• 34.6. Copyright And Disclaimer

관련자료